About us
Core Technology
Bio-Service
Investors
Careers
中文
English
About us
Introduction
Information
Announcement
Events
Corporate image
Management Team
Members
Consultants
Contact us
Core Technology
New medicine development platform
Skin diseases
ENERGI-F703
ENERGI-F701
ENERGI-F711
metabolic diseases
ENERGI-F702
Anti-inflammation
ENERGI-F704
ENERGI-F708
Diseases related to deficient mitochondrion
ENERGI-F705
ENERGI-F707
Others
ENERGI-F706
ENERGI-F709
ENERGI-F710
Bio-Service
Scientific products
Western Blot
Cell Culture Supplement
Protein Isolation
Protein Quantification
Dyes and Buffer
Supplier
Lumiprobe
Rigaku Reagents
Service
Quantitative MS and systematic biological analysis experiment service
Protein identity certification experiment service
Microarray and biological information analysis experiment service
Investors
Company
Financial information
Monthly revenue information
Financial report
Shareholders
Shareholders' Meeting
Dividend policy and dividend distribution
Public specification
Stock price information
Corporate briefing
Important information
Investment service window
Links
Corporate Governance
Member of the board
Functional committee
Various management measures
Internal audit
Head of Corporate Governance
Corporate social responsibility
Performance of corporate responsibility
Corporate Integrity Zone
Stakeholder
Careers
Investors
>
Investors
>
Shareholders
>
Important information
Important information
